SEC Form 4 · accession 0001127602-19-001880
ILLUMINA, INC. · ILMN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Malcolm Garret Hampton
Officer — SVP Clinical Genomics Group
Period of report
Jan 9, 2019
Accepted (ET)
Jan 11, 2019 · 4:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001110803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 9, 2019 | F | 327 | $305.24 | D | 7,774 | D |
Table II — derivative securities
No Table II lines on this filing.